Mangoceuticals, Inc. SEC filings MGRX

Mangoceuticals, Inc. has 240 filings in SEC EDGAR's recent list, going back to Aug 31, 2022. Its latest annual report, Form 10-K, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (material agreement). The company's fiscal year ends on December 31.

Mangoceuticals, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Oct 6, 2026 Sep 30, 2025
4 Insider transaction Oct 6, 2026 Jul 28, 2026
4 Insider transaction Oct 6, 2026 Jul 28, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 6, 2026 —
4 Insider transaction Mar 20, 2026 Jun 5, 2025
4 Insider transaction Mar 20, 2026 Mar 16, 2026
4 Insider transaction Dec 17, 2025 Dec 15, 2025
4 Insider transaction Dec 11, 2025 Dec 9, 2025
4 Insider transaction Dec 9, 2025 Dec 5, 2025
144 Notice of proposed sale Dec 3, 2025 —
4 Insider transaction Nov 26, 2025 Nov 19, 2025
144 Notice of proposed sale Nov 19, 2025 —
4 Insider transaction Sep 30, 2025 Apr 10, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 30, 2025 —
4 Insider transaction Sep 12, 2025 Sep 9, 2025
4 Insider transaction Sep 12, 2025 Sep 9, 2025
4 Insider transaction Sep 12, 2025 Sep 9, 2025
4 Insider transaction Sep 12, 2025 Sep 9, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 11, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jan 22, 2025 —
3 Initial insider ownership Jan 21, 2025 Jan 14, 2025
4 Insider transaction Nov 12, 2024 Nov 11, 2024
SC 13D/A Amended ownership over 5% (active) Aug 27, 2024 —
4 Insider transaction Aug 27, 2024 Aug 26, 2024
4 Insider transaction Jun 27, 2024 Jun 25, 2024
144/A Filing Jun 24, 2024 —
144/A Filing Jun 20, 2024 —
144 Notice of proposed sale Jun 18, 2024 —
144 Notice of proposed sale Jun 10, 2024 —
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
SC 13D/A Amended ownership over 5% (active) Jun 5, 2024 —
4 Insider transaction Jun 5, 2024 Jun 3, 2024
SC 13D/A Amended ownership over 5% (active) Jan 2, 2024 —
4 Insider transaction Dec 29, 2023 Dec 28, 2023
4 Insider transaction Oct 4, 2023 Oct 3, 2023
4 Insider transaction May 4, 2023 May 1, 2023
3 Initial insider ownership May 4, 2023 May 1, 2023
SC 13D Ownership over 5% (active) May 3, 2023 —
4 Insider transaction May 2, 2023 Apr 4, 2023
3 Initial insider ownership Mar 21, 2023 Mar 20, 2023
3 Initial insider ownership Mar 20, 2023 Mar 20, 2023
3 Initial insider ownership Mar 20, 2023 Mar 20, 2023
3 Initial insider ownership Mar 20, 2023 Mar 20, 2023
3 Initial insider ownership Mar 20, 2023 Mar 20, 2023
3 Initial insider ownership Mar 20, 2023 Mar 20, 2023

Showing 53 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Misc Health & Allied Services, NEC (SIC 8090)
Listed as
MGRX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
TX
Headquarters
Dallas, TX
SEC filer status
, Emerging growth company
SEC CIK
1938046
Former names
MANGOCEUTICALS, INC. (until Oct 9, 2026)

Other Services-Misc Health & Allied Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.